The chemoresistance mechanisms of tumor cells to doxorubicin include: (1) overexpression of membrane-associated efflux pumps and P glycoproteins mediating multidrug resistance; (2) altered expression of topoisomerase II and integrin; (3) altered glutathione levels [23]. Here, ABCB1 is linked to neoplasm.